C51H56N16O4
Neat
957.12
Linagliptin dimer; TT8UT4A8Z2; 2489212-72-6; RefChem:1088473; UNII-TT8UT4A8Z2; 8, 8'-((3R, 3'R)-(Methylenebis(azanediyl))bis(piperidine-3, 1-diyl))bis(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3, 7-dihydro-1H-purine-2, 6-dione); Linagliptin Impurity 88; 8, 8'-((3R, 3'R)-3, 3'-(methylenebis(azanediyl))bis(piperidine-3, 1-diyl))bis(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2, 6(3H and 7H)-dione)
7-but-2-ynyl-8-[(3R)-3-[[[(3R)-1-[7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-2, 6-dioxopurin-8-yl]piperidin-3-yl]amino]methylamino]piperidin-1-yl]-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2 and 6-dione
InChI=1S/C51H56N16O4/c1-7-9-25-64-42-44(60(5)50(70)66(46(42)68)29-40-54-32(3)36-19-11-13-21-38(36)56-40)58-48(64)62-23-15-17-34(27-62)52-31-53-35-18-16-24-63(28-35)49-59-45-43(65(49)26-10-8-2)47(69)67(51(71)61(45)6)30-41-55-33(4)37-20-12-14-22-39(37)57-41/h11-14,19-22,34-35,52-53H,15-18,23-31H2,1-6H3/t34-,35-/m1/s1